Tranexamic Acid in Adolescents With Heavy Menstrual Bleeding
Status:
Completed
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
This is a study to learn more about a drug called Tranexamic acid (TA), otherwise known as
Lysteda, and whether or not this drug can decrease menstrual blood loss in young women and
lead to an increase in the quality of life.
Menorrhagia in young women with bleeding disorders is typically treated with a combination of
treatments including hormonal contraceptives. However, there are barriers to hormonal
contraception use in younger adolescents.
Tranexamic acid is taken orally during the first 5 days of menstrual bleeding.
The purposes of this study include:
To test the safety and efficacy of Lysteda in adolescent females. To learn how well Lysteda
works in decreasing menstrual blood loss. To see if parents and children participating in
this study think the drug is improving their quality of life.
Lysteda has been approved by the Food and Drug Administration for use in patients > than 18
years of age but not for younger patients.